Form 4: Regal Rexnord CFO Boosts Equity Holdings via Dividend Reinvestment
Insider Transaction Report
Regal Rexnord's EVP and CFO, Robert Rehard, increased his beneficial ownership of common stock through a dividend equivalent reinvestment.
Summary
- Robert Rehard, Executive Vice President and Chief Financial Officer of Regal Rexnord Corp (RRX), acquired 24.032 shares of common stock.
- The acquisition occurred on October 14, 2025, at a price of $143.14 per share.
- This transaction represents additional restricted stock units credited to Rehard under the dividend equivalent reinvestment provision of his outstanding restricted stock unit awards, resulting from a quarterly dividend payment.
- Following this transaction, Rehard beneficially owns a total of 41,835.747 shares of common stock.
- The newly acquired restricted stock units are subject to the same terms, conditions, and vesting schedules as the original outstanding restricted stock unit awards.
Sentiment
Score: 6
Explanation: Slightly positive as it indicates an executive's continued equity participation and alignment with shareholder interests through a routine dividend reinvestment, without any negative implications or unusual activity.
Positives
- Increased alignment of executive interests with shareholders through additional equity holdings.
- Routine dividend reinvestment indicates ongoing participation in the company's equity programs and confidence in future performance.
Risks
- The value of the acquired restricted stock units and existing equity holdings is subject to market fluctuations of Regal Rexnord Corp's common stock.
- Vesting conditions apply to the restricted stock units, meaning the shares are not fully owned until those conditions are met.
Future Outlook
No specific forward-looking statements or guidance are provided in this Form 4 beyond the vesting and expiration dates of existing equity awards.
Industry Context
This Form 4 is a routine disclosure of an insider transaction, specifically an executive's acquisition of additional equity through a dividend reinvestment plan. It does not provide information to analyze broader industry trends or competitors, but rather reflects an executive's ongoing participation in the company's equity compensation plan.
Comparison to Industry Standards
- This filing is a standard Form 4 for insider transaction disclosure, which is a common regulatory requirement across publicly traded companies.
- The mechanism of dividend equivalent reinvestment for restricted stock units is a prevalent practice in executive compensation plans across various industries, aligning executive interests with shareholder returns.
- No specific comparable companies, projects, or results are mentioned in the filing to allow for a detailed comparison of performance or compensation structures against industry benchmarks.
Stakeholder Impact
- Shareholders: The EVP and CFO's increased equity stake aligns his interests more closely with shareholders, potentially fostering long-term value creation.
- Employees: No direct impact on general employees is indicated by this filing.
Next Steps
- Continued vesting of outstanding restricted stock units and Stock Appreciation Rights according to their respective schedules.
- Future dividend payments may lead to further dividend equivalent reinvestments for outstanding restricted stock unit awards.
Key Dates
| Date | Description |
|---|---|
| 05/10/2019 | Grant date for Stock Appreciation Rights (SARs) with an exercise price of $76.99. |
| 05/09/2020 | Grant date for Stock Appreciation Rights (SARs) with an exercise price of $74.04. |
| 02/18/2021 | Grant date for Stock Appreciation Rights (SARs) with an exercise price of $84.39. |
| 05/08/2021 | Grant date for Stock Appreciation Rights (SARs) with an exercise price of $78.05. |
| 02/23/2022 | Grant date for Stock Appreciation Rights (SARs) with an exercise price of $133.77. |
| 02/23/2023 | Grant date for Stock Appreciation Rights (SARs) with an exercise price of $151.27. |
| 02/23/2024 | Grant date for Stock Appreciation Rights (SARs) with an exercise price of $154.20. |
| 02/23/2025 | Grant date for Stock Appreciation Rights (SARs) with an exercise price of $168.47. |
| 10/14/2025 | Date of acquisition of 24.032 common stock shares via dividend reinvestment. |
| 05/10/2027 | Expiration date for Stock Appreciation Rights (SARs) granted on 05/10/2019. |
| 05/09/2028 | Expiration date for Stock Appreciation Rights (SARs) granted on 05/09/2020. |
| 05/08/2029 | Expiration date for Stock Appreciation Rights (SARs) granted on 05/08/2021. |
| 02/18/2030 | Expiration date for Stock Appreciation Rights (SARs) granted on 02/18/2021. |
| 02/23/2031 | Expiration date for Stock Appreciation Rights (SARs) granted on 02/23/2022. |
| 02/23/2032 | Expiration date for Stock Appreciation Rights (SARs) granted on 02/23/2023. |
| 02/23/2033 | Expiration date for Stock Appreciation Rights (SARs) granted on 02/23/2024. |
| 02/23/2034 | Expiration date for Stock Appreciation Rights (SARs) granted on 02/23/2025. |
Keywords
Regal Rexnord, RRX, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units, Dividend Reinvestment, Robert Rehard, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.